• Cadila Healthcare reported 10.8% quarter-on-quarter (QoQ) growth in its consolidated revenues for the quarter ended June (Q1FY22). On a year-on-year (YoY) basis, it increased by 14.7%.
  • Its expenses for the quarter were up by 6.7% QoQ and 11.4% YoY.
  • While the pharma major’s net profit fell by 13.4% QoQ, it grew by 28.8% on a YoY basis during the June 2021 quarter.
  • The earnings per share (EPS) of Cadila Healthcare stood at 5.5 during Q1FY22.

Cadila Healthcare’s Financial Statements for Q1FY22:

(Rs, crores) Q1FY21 Q4FY21 Q1FY22 QoQ (%) YoY (%)
Total Income 3,537 3,662 4,057 10.8% 14.7%
Total Expenses 2,965 3,095 3,302 6.7% 11.4%
Profit before tax 573 494 755 52.8% 31.8%
Tax 118 -211 142 - 19.7%
Profit after tax 438 652 565 -13.4% 28.8%
Earnings per share 4.3 6.4 5.5 - -

Data Source: BSE, Company announcements

Want to keep a tab on Indian listed companies? Open an account and get daily stock research updates from Kotak Securities.

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results